Related Experiment Video
Updated: May 5, 2026

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
Advanced Bioresponsive Drug Delivery Systems for Promoting Diabetic Vascularized Bone Regeneration
Xiaojun Zhou1,2,3, Shuo Chen1, Andrij Pich2,3
1State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Biological Science and Medical Engineering, Donghua University, Shanghai 201620, China.
Diabetic bone defects hinder healing due to a poor microenvironment. Stimuli-responsive biomaterials offer a promising approach by regulating the environment and promoting bone and blood vessel growth for better repair.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Diabetic Complications
Background:
- Diabetes mellitus (DM) significantly impairs bone regeneration due to detrimental microenvironmental factors like hyperglycemia, oxidative stress, and inflammation.
- These factors lead to delayed healing, nonunion, and compromised bone tissue quality in diabetic patients.
- Current treatments face challenges in addressing the complex biological milieu of diabetic bone defects.
Purpose of the Study:
- To systematically review the mechanisms of DM-induced impaired bone healing.
- To outline the design principles of bioresponsive drug delivery systems for bone regeneration.
- To highlight strategies for promoting vascularization in diabetic bone defects.
Main Methods:
- Literature review focusing on stimuli-responsive biomaterials and drug delivery systems.
- Analysis of mechanisms underlying impaired bone healing in diabetes.
- Evaluation of strategies coupling angiogenesis and osteogenesis for diabetic bone repair.
Main Results:
- Stimuli-responsive biomaterials can effectively regulate the diabetic microenvironment and enhance osteogenic capacity.
- Bioresponsive drug delivery systems are crucial for coordinating angiogenesis and osteogenesis.
- Remodeling the microenvironment and modulating regenerative cues are key to successful diabetic bone regeneration.
Conclusions:
- Bioresponsive drug delivery systems represent a significant advancement in treating diabetic bone defects.
- Tailoring these systems to the unique features of the diabetic microenvironment is essential for future therapeutic development.
- Integrating vascularization strategies with microenvironmental modulation holds promise for enhanced bone repair in DM patients.
More Related Videos
09:34Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair
Published on: September 7, 2017
11:20Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
Published on: March 29, 2018
Related Concept Videos
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Oral Drug Delivery Systems: Continuous-Release Systems
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetic Neuropathy